Clinical Trial Update: Angiotensin II Antagonism of TGF-Beta 1 [NA]

View source ↗

Summary

Clinical trial on Angiotensin II antagonism of TGF-Beta 1 in diabetic nephropathy and hypertension completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension

Snippet

Sponsor: Providence Health & Services | Conditions: Diabetic Nephropathy, Hypertension | NA | Status: COMPLETED